Search
Make Good Use of Your Sidebar

Use this space for anything from simple blocks of text to powerful widgets, like our Twitter and Flickr widgets. Learn more.

To access Website Management, hit the 'esc' key or use this Login link.

Blog Index
The journal that this archive was targeting has been deleted. Please update your configuration.
Navigation

Professor Rene Hurlemann, M.Sc., M.D., Ph.D.

 

Rene Hurlemann completed his M.D. at the University of Bonn, Germany, in 2001, with a thesis on the timing of intracranial memory-related ERPs in temporal lobe epilepsy. Later, he focused on stress-induced emotion-memory interactions and received his M.Sc. (2006) and Ph.D. (2007) from Maastricht University. Since completing his residency in 2008, he has served as senior physician for the Department of Psychiatry at the University of Bonn and carried on full-time clinical responsibilities running inpatient and outpatient Psychiatry clinics as well as 24/7 emergency call and resident teaching duties. In 2013, he was appointed to head the Medical Psychology Division at the University of Bonn. Since 2015, he has served as Vice Chair of the Department of Psychiatry. As clinician scientist, he is committed to research in the field of psychiatric neuroscience, with a methodological emphasis on pharmacological fMRI and connectivity-guided TMS. He is principle investigator of the “Neuromodulation of Emotion (NEMO)“ research group, for which he had obtained a 1.4 million Euro starting grant by the Ministry of Innovation, Science, Research, and Technology of the German State of North-Rhine Westfalia (MIWFT) in 2010. His current research is focused on developing cutting-edge experimental therapies along three research trajectories: (i) Oxytocin neuroscience, (ii) brain stimulation for depression, and (iii) schizophrenia early recognition and intervention. He has won several awards and stipends including the 2008 Gerd-Huber Award for PET studies in prodromal psychosis and the 2013 Helen C. Levitt Endowed Annual Visiting Professorship at the University of Iowa Carver College of Medicine. Furthermore, he is Visiting Associate in Psychology at the California Institute of Technology (Caltech), where he studies the causes and consequences of human amygdala dysfunction. In 2010, he became co-director of the Master in Affective Neuroscience joint degree program from the Universities of Maastricht & Florence. Currently, he serves as ad-hoc referee for 20 international public funding agencies and 80 peer-reviewed journals, and has become member of 10 professional societies including the American College of Neuropsychopharmacology (ACNP). Due to his interest in promoting precision medicine in Psychiatry, he has joined several committees including the World Psychiatric Association (WPA) section on Personalized Medicine in Psychiatry and the editorial boards of Personalized Medicine in Psychiatry (Elsevier) and Der Nervenarzt (Springer Nature). In 2019, Rene Hurlemann received an offer for an academic chair position in Psychiatry in northwestern Germany, which currently is under negotiation.

 

Related links:

  • Medical Psychology Division, University of Bonn, 53105 Bonn, Germany (content in German) Link 
  • Department of Psychiatry, University of Bonn, 53105 Bonn, Germany (content in German) Link
  • Bonn Schizophrenia Early Diagnosis and Treatment Center (FEP) (content in German) Link
  • International Master in Affective Neuroscience Program Link 
  • Google Scholar Citations Profile Link 
  • ORCiD ID: 0000-0003-2628-565X Link
  • One-page CV: German & English

 

Top 5 publications in 2019

  • Hurlemann R, Scheele D, Kinfe TM, Berger R, Philipsen A, Voncken M, Kuypers KPC, Schruers K (2019) Increased temporal discounting in social anxiety disorder normalizes after oxytocin treatment. Psychotherapy & Psychosomatics 88: 55 - 57 [IF 13.1] PDF
  • Scheele D, Lieberz J, Patin A, Engels C, Schneider L, Stoffel-Wagner B, Becker B, Hurlemann R (2019) Trauma disclosure moderates the effects of oxytocin on intrusions and neural responses to fear. Psychotherapy & Psychosomatics 88: 61 - 63 [IF 13.1] PDF 
  • Hurlemann R & Marsh N (2019) Unraveling the role of oxytocin in the motivational structure of conflict. Behavioral & Brain Sciences (BBS) (in press) [IF 15.1]
  • Mutz J, Vipulananthan V, Carter B, Hurlemann R, Fu CHY, Young AH (2019) Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. British Medical Journal (in press) [IF 23.6] PDF
  • Hasan MT, Althammer F, Silva da Gouveia M, Goyon S, Eliava M, Lefevre A, Kerspern D, Schimmer J, Raftogianni A, Wahis J, Knobloch-Bollmann HS, Tang Y, Liu X, Jain A,  Chavant V, Goumon Y, Weislogel J-M, Hurlemann R, Herpertz SC, Pitzer C, Darbon P, Dogbevia GK, Bertocchi I, Larkum ME, Sprengel R, Bading H, Charlet A, Grinevich V (2019) Fear memory engram and its plasticity in the hypothalamic oxytocin system. Neuron (in press) [IF 14.3]

Abbreviations: IF, Journal Impact Factor 

 

Latest book

  • Hurlemann R & Grinevich V (2018) Behavioral Pharmacology of Neuropeptides: Oxytocin (Current Topics in Behavioral Neurosciences, Volume 35) Springer [978-3319637389] Link